A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma
As a non-invasive imaging biomarker, PET/CT radiomics holds potential for predicting high-risk cytogenetic status and facilitating patient prognosis stratification Further large-scale, multi-center prospective validations are essential to confirm its utility for personalized therapeutic decision-making in MM.
Authors
- Jingxin Han
- Yu Fan (ORCID: https://orcid.org/0000-0003-4288-2999)
- Xuehai Ding
- Chunkang Chang (ORCID: https://orcid.org/0000-0001-5318-5879)
- Xiaohu Ren
- Hong Chen (ORCID: https://orcid.org/0000-0002-5412-7467)
- Qi He (ORCID: https://orcid.org/0000-0001-6000-2655)
- Haozhe Huang (ORCID: https://orcid.org/0000-0001-6765-5931)
- Quanyong Luo (ORCID: https://orcid.org/0000-0002-8778-5415)
Institutions
- Shanghai University of Engineering Science (CN)
- Fudan University Shanghai Cancer Center (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- EJNMMI Research
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1186/s13550-025-01321-8
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00